期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
In vivo anticancer activity of vanillin semicarbazone 被引量:2
1
作者 Shaikh m mohsin Ali m abul kalam azad +5 位作者 mele Jesmin Shamim Ahsan m mijanur Rahman Jahan Ara Khanam m Nazrul Islam Sha m Shahan Shahriar 《Asian Pacific Journal of Tropical Biomedicine》 SCIE CAS 2012年第6期438-442,共5页
Objective:To evaluate the anticancer activity of vanillin semicarbazone(VSC) against Ehrlich ascites carcinoma(EAC) cells in Swiss albino mice.Methods:The compound VSC at three doses(5, 7.5 and 10 mg/kg i.p.) was admi... Objective:To evaluate the anticancer activity of vanillin semicarbazone(VSC) against Ehrlich ascites carcinoma(EAC) cells in Swiss albino mice.Methods:The compound VSC at three doses(5, 7.5 and 10 mg/kg i.p.) was administered into the intraperitoneal cavity of the EAC inoculated mice to observe its efficiency by studying the cell growth inhibition, reduction of tumour weight,enhancement of survival time as well as the changes in depleted hematological parameters. Allsuch parameters were also studied with a known standard drug bleomycin at the dose of 0.3 mg/kg(i.p.).Results:Among the doses studied, 10 mg/kg(i.p.) was found to be quite comparable in potency to that of bleomycin at the dose of 0.3 mg/kg(i.p.). The host toxic effects of VSC was found to be negligible.Conclusions:It can be concluded that VSC can therefore be considered as potent anticancer agent. 展开更多
关键词 ANTICANCER activity Ehrlich ASCITES CARCINOMA Schiffbase
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部